{"id":987120,"date":"2026-07-30T07:21:48","date_gmt":"2026-07-30T11:21:48","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/"},"modified":"2026-07-30T07:21:48","modified_gmt":"2026-07-30T11:21:48","slug":"novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/","title":{"rendered":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">GAITHERSBURG, Md.<\/span>, <span class=\"legendSpanClass\">July 30, 2026<\/span> \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S. financial markets on Thursday, August 6, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Conference call details:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Date:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">August 6, 2026<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Time:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">8:30 a.m. ET<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">URL to register phone:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4742120-1&amp;h=3421621254&amp;u=https%3A%2F%2Fregistrations.events%2Feasyconnect%2F9097916%2FrecIT4JFZJbZ2wv9T%2F&amp;a=Register+Here\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">Register Here<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Dial-in number:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Webcast:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">The live webcast can be accessed at\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4742120-1&amp;h=2041229361&amp;u=https%3A%2F%2Fir.novavax.com%2Fevents%23future%3A2023%3A2&amp;a=ir.novavax.com%2Fevents\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">ir.novavax.com\/events<\/a><\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<ul type=\"disc\">\n<li>\n          <i>Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.<\/i>\n        <\/li>\n<li>\n          <i>Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.<\/i>\n        <\/li>\n<li>\n          <i>To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled start time.<\/i>\n        <\/li>\n<\/ul>\n<p>A replay of the webcast will be available at <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4742120-1&amp;h=2041229361&amp;u=https%3A%2F%2Fir.novavax.com%2Fevents%23future%3A2023%3A2&amp;a=ir.novavax.com%2Fevents\" target=\"_blank\" rel=\"nofollow\">ir.novavax.com\/events<\/a>\u00a0and over the phone approximately two hours after the event:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Replay dial-in number:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(+1) 800-770-2030 (U.S.) or (+1) 609-800-9909 (International)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Passcode:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\" nowrap=\"nowrap\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">9097916#<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\n        <b>About Novavax<br \/><\/b>Novavax, Inc. (Nasdaq: NVAX) tackles some of the world&#8217;s most pressing health challenges with its scientific\u00a0expertise\u00a0in vaccines and its proven technology platform, including its Matrix-M<sup>\u00ae<\/sup>\u00a0adjuvant and protein-based nanoparticles. The Company&#8217;s corporate growth strategy is designed to deliver value via three key strategic pillars:\u00a0partnering\u00a0its technology, capital-efficient research and development (R&amp;D)\u00a0innovation\u00a0and a lean and efficient operating model. This includes maximizing impact through partnerships for its marketed products (Nuvaxovid\u2122, R21\/Matrix-M\u2122), Matrix technology and R&amp;D assets. Please visit\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4742120-1&amp;h=2311796983&amp;u=https%3A%2F%2Fwww.novavax.com%2F&amp;a=novavax.com\" target=\"_blank\" rel=\"nofollow\">novavax.com<\/a>\u00a0and\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4742120-1&amp;h=858470105&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnovavax&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a>\u00a0for more information.\u00a0<\/p>\n<p>\n        <b>Contacts: <\/b>\n      <\/p>\n<p>\n        <u>Investors<br \/><\/u>Naina Zaman\u00a0<br \/>844-668-2829\u00a0<br \/><a href=\"mailto:ir@novavax.com\" target=\"_blank\" rel=\"nofollow\">ir@novavax.com<\/a>\u00a0<\/p>\n<p>\n        <u>Media<\/u>\u00a0<br \/>Yvonne Sprow\u00a0<br \/>844-264-8571\u00a0<br \/><a href=\"mailto:media@novavax.com\" target=\"_blank\" rel=\"nofollow\">media@novavax.com<\/a>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder4731\">\n<p>\n          <img decoding=\"async\" src=\"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885\" title=\"Novavax Logo\" alt=\"Novavax Logo\" \/>\n        <\/p>\n<\/p><\/div>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=PH15493&amp;sd=2026-07-30\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026-302838333.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026-302838333.html<\/a><\/p>\n<p>SOURCE Novavax, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH15493&amp;Transmission_Id=202607300700PR_NEWS_USPR_____PH15493&amp;DateId=20260730\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire GAITHERSBURG, Md., July 30, 2026 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S. financial markets on Thursday, August 6, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights. Conference call details: Date: August 6, 2026 Time: 8:30 a.m. ET URL to register phone: Register Here Dial-in number: (+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International) Webcast: The live webcast can be accessed at\u00a0ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-987120","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire GAITHERSBURG, Md., July 30, 2026 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S. financial markets on Thursday, August 6, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights. Conference call details: Date: August 6, 2026 Time: 8:30 a.m. ET URL to register phone: Register Here Dial-in number: (+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International) Webcast: The live webcast can be accessed at\u00a0ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to &hellip; Continue reading &quot;Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T11:21:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026\",\"datePublished\":\"2026-07-30T11:21:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/\"},\"wordCount\":346,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1529939\\\/Novavax-High-Res-Logo.jpg?id=OA2803885\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/\",\"name\":\"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1529939\\\/Novavax-High-Res-Logo.jpg?id=OA2803885\",\"datePublished\":\"2026-07-30T11:21:48+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1529939\\\/Novavax-High-Res-Logo.jpg?id=OA2803885\",\"contentUrl\":\"https:\\\/\\\/mmx.prnewswire.com\\\/media\\\/MS1529939\\\/Novavax-High-Res-Logo.jpg?id=OA2803885\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/","og_locale":"en_US","og_type":"article","og_title":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk","og_description":"PR Newswire GAITHERSBURG, Md., July 30, 2026 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX) today announced that the Company plans to release its second quarter 2026 financial results before the open of the U.S. financial markets on Thursday, August 6, 2026. Following the release, Company management will host a webcast and conference call at 8:30 a.m. Eastern Time (ET) to discuss financial results and operational highlights. Conference call details: Date: August 6, 2026 Time: 8:30 a.m. ET URL to register phone: Register Here Dial-in number: (+1) 888-880-3330 (U.S.) or (+1) 646-357-8766 (International) Webcast: The live webcast can be accessed at\u00a0ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to &hellip; Continue reading \"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-30T11:21:48+00:00","og_image":[{"url":"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026","datePublished":"2026-07-30T11:21:48+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/"},"wordCount":346,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/","name":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885","datePublished":"2026-07-30T11:21:48+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#primaryimage","url":"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885","contentUrl":"https:\/\/mmx.prnewswire.com\/media\/MS1529939\/Novavax-High-Res-Logo.jpg?id=OA2803885"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-report-second-quarter-2026-financial-results-on-august-6-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=987120"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987120\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=987120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=987120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=987120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}